291 related articles for article (PubMed ID: 25542188)
1. Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.
Theile D; Haefeli WE; Weiss J
Endocrine; 2015 Aug; 49(3):842-53. PubMed ID: 25542188
[TBL] [Abstract][Full Text] [Related]
2. Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma.
Kroiss M; Plonné D; Kendl S; Schirmer D; Ronchi CL; Schirbel A; Zink M; Lapa C; Klinker H; Fassnacht M; Heinz W; Sbiera S
Eur J Endocrinol; 2016 Mar; 174(3):343-53. PubMed ID: 26671975
[TBL] [Abstract][Full Text] [Related]
3. A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients.
Garg MB; Sakoff JA; Ackland SP
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2201-5. PubMed ID: 21719363
[TBL] [Abstract][Full Text] [Related]
4. Determination of mitotane (o,p-DDD) and its metabolites o,p-DDA and o,p-DDE in plasma by high-performance liquid chromatography.
Andersen A; Kasperlik-Zaluska AA; Warren DJ
Ther Drug Monit; 1999 Jun; 21(3):355-9. PubMed ID: 10365653
[TBL] [Abstract][Full Text] [Related]
5. A high-pressure liquid chromatographic method for measuring mitotane [1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethane] and its metabolite 1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethene in plasma.
Andersen A; Warren DJ; Nome O; Vesterhus L; Slørdal L
Ther Drug Monit; 1995 Oct; 17(5):526-31. PubMed ID: 8585118
[TBL] [Abstract][Full Text] [Related]
6. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.
Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A
Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009
[TBL] [Abstract][Full Text] [Related]
7. Comparative CYP-dependent binding of the adrenocortical toxicants 3-methylsulfonyl-DDE and o,p'-DDD in Y-1 adrenal cells.
Hermansson V; Asp V; Bergman A; Bergström U; Brandt I
Arch Toxicol; 2007 Nov; 81(11):793-801. PubMed ID: 17487473
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p'-DDD (mitotane) in Minipigs.
Hermansson V; Cantillana T; Hovander L; Bergman A; Ljungvall K; Magnusson U; Törneke K; Brandt I
Cancer Chemother Pharmacol; 2008 Feb; 61(2):267-74. PubMed ID: 17431626
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450-catalyzed binding of 3-methylsulfonyl-DDE and o,p'-DDD in human adrenal zona fasciculata/reticularis.
Lindhe O; Skogseid B; Brandt I
J Clin Endocrinol Metab; 2002 Mar; 87(3):1319-26. PubMed ID: 11889204
[TBL] [Abstract][Full Text] [Related]
10. Two-dimensional chromatography for enantiomeric analysis of mitotane and its metabolite o,p'-DDA in patients with adrenocortical carcinoma indicates enantioselective metabolism.
Stadler G; de Almeida Veiga A; Rita Corso C; Bach de Assis C; de Toledo Nogueira B; Regina Rocha Martins L; Cruz Bonk B; Lada Degaut Pontes F; Cavalcante de Figueiredo B; Mera de Souza L
Bioorg Chem; 2023 Dec; 141():106835. PubMed ID: 37713949
[TBL] [Abstract][Full Text] [Related]
11. Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; o,p'-DDD] and its p,p'- and m,p'-isomers.
Cai W; Benitez R; Counsell RE; Djanegara T; Schteingart DE; Sinsheimer JE; Wotring LL
Biochem Pharmacol; 1995 May; 49(10):1483-9. PubMed ID: 7763292
[TBL] [Abstract][Full Text] [Related]
12. Mitotane effects in a H295R xenograft model of adjuvant treatment of adrenocortical cancer.
Lindhe O; Skogseid B
Horm Metab Res; 2010 Sep; 42(10):725-30. PubMed ID: 20665429
[TBL] [Abstract][Full Text] [Related]
13. Effects of o,p'-DDE, a Mitotane Metabolite, in an Adrenocortical Carcinoma Cell Line.
Bach C; Corso CR; Veiga AA; Paraizo MM; de Souza LM
Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558937
[TBL] [Abstract][Full Text] [Related]
14. Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up.
Kasperlik-Zaluska AA; Cichocki A
J Exp Ther Oncol; 2005; 5(2):125-32. PubMed ID: 16471038
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of the adrenocortical carcinoma with Lysodren (o,p'-DDD). Therapeutic management by monitoring o,p'-DDD blood levels].
Heilmann P; Wagner P; Nawroth PP; Ziegler R
Med Klin (Munich); 2001 Jul; 96(7):371-7. PubMed ID: 11494911
[TBL] [Abstract][Full Text] [Related]
16. [Metabolism of o,p'-DDD (mitotane) in human and animals. Actual notions and practical deductions (author's transl)].
Touitou Y; Bogdan A; Legrand JC; Desgrez P
Ann Endocrinol (Paris); 1977; 38(1):13-25. PubMed ID: 324349
[TBL] [Abstract][Full Text] [Related]
17. Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma.
Cusato J; De Francia S; Allegra S; Carrella S; Pirro E; Piccione FM; De Martino F; Ferrero A; Daffara FC; Terzolo M; Berruti A; Di Carlo F; Tampellini M; D'Avolio A
J Pharm Pharmacol; 2017 Nov; 69(11):1524-1530. PubMed ID: 28809444
[TBL] [Abstract][Full Text] [Related]
18. o,p'-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacement.
Hogan TF; Citrin DL; Johnson BM; Nakamura S; Davis TE; Borden EC
Cancer; 1978 Nov; 42(5):2177-81. PubMed ID: 719602
[TBL] [Abstract][Full Text] [Related]
19. [Levels of dichlorodiphenyltrichloroethane internal exposure levels in pregnant women of Xiamen and influencing factors].
Yu XS; He J; Chen JH; Lai ZB; Su YH; Shi MM; Huang ZX; Cheng QJ; Ke XY; Zhao BH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Nov; 50(11):982-989. PubMed ID: 27903362
[No Abstract] [Full Text] [Related]
20. Toxicity, dioxin-like activities, and endocrine effects of DDT metabolites--DDA, DDMU, DDMS, and DDCN.
Wetterauer B; Ricking M; Otte JC; Hallare AV; Rastall A; Erdinger L; Schwarzbauer J; Braunbeck T; Hollert H
Environ Sci Pollut Res Int; 2012 Feb; 19(2):403-15. PubMed ID: 21792584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
